Engineered for absolute fluid integrity, validated zero-risk sterile connection, and seamless operation across biopharmaceutical pilot lines and commercial manufacturing.
Daejeon Metropolitan City stands as the undisputed R&D epicenter and technological engine of South Korea. Home to Daedeok Innopolis (Daedeok Science Town), the Korea Advanced Institute of Science and Technology (KAIST), and the Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon hosts over 600 high-tech biotech enterprises, innovative biopharmaceutical startups, and contract development and manufacturing organizations (CDMOs). As Daejeon transitions from early-stage target discovery to clinical-scale and commercial production of advanced therapeutics—including Antibody-Drug Conjugates (ADCs), mRNA vaccines, cell and gene therapies (CGTs), and recombinant proteins—the demand for ultra-pure, leak-free, and validated zero-risk fluid transfer assemblies has scaled exponentially.
In modern bioprocessing, contamination during fluid transfer can cause catastrophic batch failures, resulting in lost production cycles worth millions of dollars and severe regulatory setbacks from agencies like South Korea's Ministry of Food and Drug Safety (MFDS), US FDA, and EMA. Aseptic Connection and Disconnection Kits are the fundamental backbone safeguarding process integrity. These single-use fluid pathway assemblies enable operators to connect fluid lines (bioreactors, filtration skids, storage bags, and fill-finish systems) and disconnect them cleanly in unclassified environmental conditions (Grade C or D cleanrooms or non-sterile space) without compromising product sterility or exposing technicians to hazardous active pharmaceutical ingredients (APIs).
For Daejeon-based biopharmaceutical pioneers, securing robust, fully compliant, and scalable aseptic connection/disconnection kits is no longer just a supply chain necessity—it is a core strategic advantage. Our comprehensive product portfolio bridges high-precision manufacturing, rigorous bio-compatibility compliance (USP Class VI, ISO 10993, ISO 11137), and optimized cost structures to serve Daejeon’s rapidly growing biotech corridor.
Traditional male-female gendered connection configurations increase inventory complexity and risk operator mismatches during critical fluid transfers. Modern single-use aseptic connection technology incorporates genderless interfaces featuring dual protective membrane shields. Upon actuation, the sterile internal faces snap into alignment, and the protective films are peeled away simultaneously, creating an uncompromised fluid pathway with zero risk of ambient ingress.
When disconnecting fluid manifolds post-harvest, post-filtration, or during intermediate sampling, liquid residue inside the tubing presents a major contamination hazard. Advanced disconnection kits utilize heat-sealing thermoplastic tubing (TPE) or sanitary mechanical disconnection collars. Thermal sealing fuses the tubing internal walls under controlled heat and compression, severing the connection while maintaining a leak-proof, hermetically sealed end cap on both fluid lines.
| Performance Metric | Traditional Stainless Steel CIP/SIP Connection | Single-Use Aseptic Connection Kits | U-Care Medical Optimized Kits |
|---|---|---|---|
| Sterilization Validation | Complex, Steam-in-Place (SIP) required | Pre-validated Gamma Irradiated (25-40 kGy) | Gamma & E-Beam Validated (SAL 10⁻⁶) |
| Turnaround & Setup Time | 4 to 8 Hours (Cleaning & Validation) | < 5 Minutes Plug-and-Play | < 2 Minutes High-Speed Modular Connection |
| Cross-Contamination Risk | Moderate (Residual batch risks) | Near Zero (Single-use non-contact) | Zero (Dual membrane & 100% leak testing) |
| Capital Outlay (CAPEX) | Very High (Hard piping & valves) | Low (OpEx based) | Optimized Cost Structure (Direct Factory Export) |
| Regulatory Traceability | Manual CIP/SIP logging | Batch Lot Traceability | Full Lot Traceability & Complete Validation Pack |
Combining precision engineering, rapid delivery cycles, and rigorous quality systems from Changzhou to Daejeon Bio-Clusters.
Facilitating zero-contamination seed train expansion and media addition into benchtop and pilot-scale bioreactors across Daedeok Science Town research centers.
Allowing bio-engineers to extract representative cell culture or harvest samples repeatedly without exposing the main vessel fluid pathway to ambient air.
Enabling safe, sealed disconnection for toxic payload-conjugation processes in Daejeon’s advanced targeted cancer therapy development pipelines.
Connecting ultrafiltration/diafiltration (UF/DF) skids to intermediate holding bags with zero holdup volume and high pressure resistance.
Ensuring uncompromised transfer from bulk final drug substance formulation to automated filling needles in CGMP compliant cleanrooms.
Equipped with low-temperature resistant silicone or TPE tubing for sub-zero (-80°C to -196°C) cell therapy and viral vector preservation.
Changzhou U-Care Medical Co., Ltd. was established in 2014 and is located in Changzhou, Jiangsu Province, within the core region of the Yangtze River Delta—one of China’s most dynamic and economically advanced areas. Benefiting from a strategic location and convenient transportation network, the company enjoys strong access to both domestic and international markets.
U-Care Medical has accumulated extensive experience in the manufacturing of medical and pharmaceutical packaging products. The company is dedicated to the research, development, and production of high-quality disposable medical and pharmaceutical packaging materials. With a focus on innovation and reliability, U-Care strives to provide safe, efficient, and customized solutions to meet the evolving needs of healthcare and pharmaceutical industries worldwide.
The company is equipped with modern production facilities and adheres strictly to industry standards and quality management systems. From raw material selection to final product delivery, every step is carefully controlled to ensure product consistency, safety, and compliance with international regulations.
We always place product quality at the highest priority. Customer satisfaction is the driving force behind our continuous improvement and development.
We are committed to building long-term partnerships with our clients by adhering to honest and transparent business practices, never compromising on ethics or authenticity.
Through continuous innovation and refinement, we strive to develop more practical, reliable, and high-performance packaging solutions that support the stable and safe use of our customers’ products.
To become a trusted global provider of medical and pharmaceutical packaging solutions by consistently delivering superior quality, innovation, and customer-focused services.
To support the healthcare industry with safe, reliable, and efficient packaging products, contributing to better protection and delivery of medical products worldwide.
Explore our full spectrum of aseptic transfer, diaphragm valve, sight glass, filter housing, and specialized connection components ready for export to Daejeon.
In-depth validation, regulatory compliance, and logistics guidance for procuring single-use aseptic transfer kits.